DATROWAY® approved in Japan as the first TROP-2 directed therapy for patients with previously treated...

Porton Pharma Solutions and Dragon Sail Pharmaceutical form strategic partnership to build a new ecosystem...

OBI Pharma enters collaboration with GlyTech to expand GlycOBI® enabling technologies outreach in Japan and...

WuXi Biologics and Hangzhou DAC signed research service agreement with Aadi Bioscience on three novel...

IND application for a phase I/II clinical study of anti-HER2 bispecific ADC subcutaneous co-formulation JSKN033...

Datopotamab deruxtecan application in the EU for patients with advanced nonsquamous non-small cell lung cancer...